Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
Hepatology (Baltimore, Md.) - 79(2024), 3 vom: 01. März, Seite 731-743 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Levy, Cynthia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
5-Aminolevulinate Synthetase |
|---|
| Anmerkungen: |
Date Completed 19.02.2024 Date Revised 03.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/HEP.0000000000000546 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360051162 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360051162 | ||
| 003 | DE-627 | ||
| 005 | 20240403234910.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/HEP.0000000000000546 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1362.xml |
| 035 | |a (DE-627)NLM360051162 | ||
| 035 | |a (NLM)37505211 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Levy, Cynthia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2024 | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Ferrochelatase |2 NLM | |
| 650 | 7 | |a EC 4.99.1.1 |2 NLM | |
| 650 | 7 | |a 5-Aminolevulinate Synthetase |2 NLM | |
| 650 | 7 | |a EC 2.3.1.37 |2 NLM | |
| 700 | 1 | |a Dickey, Amy K |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Bruce |e verfasserin |4 aut | |
| 700 | 1 | |a Thapar, Manish |e verfasserin |4 aut | |
| 700 | 1 | |a Naik, Hetanshi |e verfasserin |4 aut | |
| 700 | 1 | |a Keel, Siobán B |e verfasserin |4 aut | |
| 700 | 1 | |a Saberi, Behnam |e verfasserin |4 aut | |
| 700 | 1 | |a Beaven, Simon W |e verfasserin |4 aut | |
| 700 | 1 | |a Rudnick, Sean R |e verfasserin |4 aut | |
| 700 | 1 | |a Elmariah, Sarina B |e verfasserin |4 aut | |
| 700 | 1 | |a Erwin, Angelika L |e verfasserin |4 aut | |
| 700 | 1 | |a Goddu, Robert J |e verfasserin |4 aut | |
| 700 | 1 | |a Hedstrom, Karli |e verfasserin |4 aut | |
| 700 | 1 | |a Leaf, Rebecca Karp |e verfasserin |4 aut | |
| 700 | 1 | |a Kazamel, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Mazepa, Marshall |e verfasserin |4 aut | |
| 700 | 1 | |a Philpotts, Lisa Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Quigley, John |e verfasserin |4 aut | |
| 700 | 1 | |a Raef, Haya |e verfasserin |4 aut | |
| 700 | 1 | |a Ungar, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Karl E |e verfasserin |4 aut | |
| 700 | 1 | |a Balwani, Manisha |e verfasserin |4 aut | |
| 700 | 0 | |a Porphyrias Consortium of the Rare Diseases Clinical Network |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hepatology (Baltimore, Md.) |d 1983 |g 79(2024), 3 vom: 01. März, Seite 731-743 |w (DE-627)NLM012603902 |x 1527-3350 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:731-743 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/HEP.0000000000000546 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2024 |e 3 |b 01 |c 03 |h 731-743 | ||